Ascent Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,427
Closed -$981K 160
2023
Q4
$981K Sell
12,427
-373
-3% -$26.5K 0.16% 99
2023
Q3
$894K Buy
12,800
+566
+5% +$40.1K 0.16% 104
2023
Q2
$846K Buy
12,234
+1,526
+14% +$109K 0.15% 108
2023
Q1
$796K Buy
+10,708
New +$898K 0.16% 111
2022
Q1
Sell
-2,500
Closed -$201K 152
2021
Q4
$201K Buy
+2,500
New +$231K 0.04% 143
2020
Q2
Sell
-5,172
Closed -$307K 110
2020
Q1
$307K Sell
5,172
-349
-6% -$23.3K 0.11% 90
2019
Q4
$410K Buy
5,521
+752
+16% +$52.8K 0.12% 89
2019
Q3
$300K Sell
4,769
-482
-9% -$28.6K 0.09% 99
2019
Q2
$287K Buy
5,251
+71
+1% +$3.82K 0.09% 101
2019
Q1
$280K Buy
+5,180
New +$320K 0.09% 103
2017
Q2
Sell
-8,690
Closed -$683K 121
2017
Q1
$683K Buy
8,690
+211
+2% +$16.8K 0.31% 67
2016
Q4
$669K Buy
8,479
+1,569
+23% +$127K 0.33% 64
2016
Q3
$615K Sell
6,910
-105
-1% -$9.91K 0.31% 66
2016
Q2
$671K Sell
7,015
-45
-0.6% -$4.49K 0.35% 64
2016
Q1
$733K Buy
7,060
+740
+12% +$72K 0.39% 62
2015
Q4
$618K Buy
+6,320
New +$619K 0.34% 69

Other funds holding CVS

Ascent Wealth Partners's CVS Position: Q1 2024 in Review

Ascent Wealth Partners sold out of CVS Health (CVS) in Q1 2024, closing a stake of 12,427 shares — an estimated $981K sold.

Ascent Wealth Partners first reported a position in CVS in Q4 2015 and held it in 16 quarters. The position peaked at $981K in Q4 2023. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Ascent Wealth Partners reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Ascent Wealth Partners sold 12,427 CVS Health shares in Q1 2024, an estimated $981K.
  • Ascent Wealth Partners first reported a position in CVS Health in Q4 2015 and held it in 16 quarters.
  • Ascent Wealth Partners's CVS Health position peaked at $981K in Q4 2023.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Ascent Wealth Partners's 13F filing for Q1 2024, filed 1 May 2024.